257 related articles for article (PubMed ID: 14759987)
1. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice.
Zhang Y; Yoneyama H; Wang Y; Ishikawa S; Hashimoto S; Gao JL; Murphy P; Matsushima K
J Natl Cancer Inst; 2004 Feb; 96(3):201-9. PubMed ID: 14759987
[TBL] [Abstract][Full Text] [Related]
2. MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood.
He S; Cao Q; Yoneyama H; Ge H; Zhang Y; Zhang Y
J Leukoc Biol; 2008 Dec; 84(6):1549-56. PubMed ID: 18791167
[TBL] [Abstract][Full Text] [Related]
3. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
4. Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells.
Drakes ML; Zahorchak AF; Takayama T; Lu L; Thomson AW
Transpl Immunol; 2000 Mar; 8(1):17-29. PubMed ID: 10834607
[TBL] [Abstract][Full Text] [Related]
5. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
[TBL] [Abstract][Full Text] [Related]
7. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
8. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1.
Broxmeyer HE; Cooper S; Hangoc G; Gao JL; Murphy PM
J Exp Med; 1999 Jun; 189(12):1987-92. PubMed ID: 10377195
[TBL] [Abstract][Full Text] [Related]
9. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
[TBL] [Abstract][Full Text] [Related]
10. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.
Chen Z; Moyana T; Saxena A; Warrington R; Jia Z; Xiang J
Int J Cancer; 2001 Aug; 93(4):539-48. PubMed ID: 11477558
[TBL] [Abstract][Full Text] [Related]
11. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
[TBL] [Abstract][Full Text] [Related]
13. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines.
Gouwy M; De Buck M; Pörtner N; Opdenakker G; Proost P; Struyf S; Van Damme J
Eur J Immunol; 2015 Jan; 45(1):101-12. PubMed ID: 25345597
[TBL] [Abstract][Full Text] [Related]
16. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages.
Jarmin DI; Nibbs RJ; Jamieson T; de Bono JS; Graham GJ
Exp Hematol; 1999 Dec; 27(12):1735-45. PubMed ID: 10641591
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
[TBL] [Abstract][Full Text] [Related]
19. Host absence of CCR5 potentiates dendritic cell vaccination.
Ng-Cashin J; Kuhns JJ; Burkett SE; Powderly JD; Craven RR; van Deventer HW; Kirby SL; Serody JS
J Immunol; 2003 Apr; 170(8):4201-8. PubMed ID: 12682253
[TBL] [Abstract][Full Text] [Related]
20. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
